Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Alex Gorovets"'
Autor:
Paul W. Price, Banu A Karimi-Shah, Libero Marzella, Merriline M. Satyamitra, Sue-Jane Wang, Nushin Todd, David R. Cassatt, Rosemary Roberts, Alex Gorovets
Publikováno v:
Radiat Res
Research and development of medical countermeasures (MCMs) for radiation-induced lung injury relies on the availability of animal models with well-characterized pathophysiology, allowing effective bridging to humans. To develop useful animal models,
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:27-28
Autor:
Alex Gorovets, James Kaiser, Robert Boucher, Ira Krefting, Lucie Yang, Louis Marzella, Dwaine Rieves
Publikováno v:
Radiology. 265(1)
In 2007, the Food and Drug Administration requested that manufacturers of all approved gadolinium-based contrast agents (GBCAs), drugs widely used in magnetic resonance imaging, use nearly identical text in their product labeling to describe the risk
Publikováno v:
Formulary Watch. 11/30/2021, p1-1. 1p.
Autor:
DeLONG, MARK
Publikováno v:
Conquer. Dec2021, Vol. 7 Issue 6, p10-12. 3p.
Autor:
Cassatt, David R., Gorovets, Alex, Karimi-Shah, Banu, Roberts, Rosemary, Price, Paul W., Satyamitra, Merriline M., Todd, Nushin, Wang, Sue-Jane, Marzella, Libero
Publikováno v:
Radiation Research; Apr2022, Vol. 197 Issue 4, p415-433, 19p
Publikováno v:
Oncology Nurse-APN/PA; Feb2022, Vol. 15 Issue 1, p6-17, 4p
Publikováno v:
Journal of Nuclear Medicine; 2021 Supplement, Vol. 62, p1-1858, 1842p
Publikováno v:
Conquer. Dec2021, Vol. 7 Issue 6, p12-12. 1/3p.
Autor:
Sun, Haihao, Temeck, Jean W., Chambers, Wiley, Perkins, Ginger, Bonnel, Renan, Murphy, Dianne
Publikováno v:
Therapeutic Innovation & Regulatory Science; Mar2018, Vol. 52 Issue 2, p199-205, 7p